Skip to main content
SpringerLink
Log in
Book cover

Die Gynäkologie pp 61–103Cite as

Klimakterium, Postmenopause und Senium

  • Chapter

  • 2146 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahlborg HG, Johnell O, Turner CH et al. (2003) Bone loss and bone size after menopause. N Engl J Med 349: 327–224

    Article  PubMed  Google Scholar 

  • Akhrass F, Evans AT, Wang Y, Rich S, Kannan CR, Fogelfeld L, Mazzone T (2003) Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 88: 5611–5614

    Article  PubMed  CAS  Google Scholar 

  • Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM (2002) Adrenal antibodies detect asymptomatic autoimmune adrenal insufficiency in young women with spontaneous premature ovarian failure. Human Reprod 17: 2096–2100

    Article  CAS  Google Scholar 

  • Barhan S, Ezenagu L (1997) Vulvar problems in elderly women. Postgrad. Med. 102: 121–132

    PubMed  CAS  Google Scholar 

  • Barrett-Connor E (1996) The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence. Maturitas 23: 227–234

    Article  PubMed  CAS  Google Scholar 

  • Birkhäuser M, Braendle W, Keller PJ, Diesel L, Kuhl H, Neulen J (2004) Empfehlungen zur Substitution mit Estrogenen und Gestagenen im Klimakterium und in der Postmenopause. J Menopause 2: 28–36

    Google Scholar 

  • Black DM, Greenspan SL, Ensrud KE et al. (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207–1215

    Article  PubMed  CAS  Google Scholar 

  • Black DM, Thrompson DE, Bauer DC et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. J Clin Endocrinol Metab 85: 4118–4124

    Article  PubMed  CAS  Google Scholar 

  • Boivin G, Lips P, Ott SM et al. (2003) Contribution of raloxifene and calcium and vitamin d3 supplementation to the increase in the degree of mineralization of bone in postmenopausal women. J Clin Endocrinol Metab 88: 4199–4205

    Article  PubMed  CAS  Google Scholar 

  • Bone HG, Hosking D, Devogelaer J-P et al. (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. Obstet Gynecol Surv 59(8): 597–598

    Article  Google Scholar 

  • Burger H, Archer D, Barlow D et al. (2004) Practical recommendations for hormone replacement therapy in the peri-and postmenopause. Climacteric 7: 210–216

    Article  PubMed  Google Scholar 

  • Burke JR, Morgenlander JC (1999) Update on Alzheimer’s disease. Postgrad Med 106: 85–96

    PubMed  CAS  Google Scholar 

  • Bush TL (1996) Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy. Eur Heart J 17(Suppl. D): 9–14

    PubMed  CAS  Google Scholar 

  • Chlebowski RT, McTiernan A (2001) Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst 93 754ff.

    Google Scholar 

  • Chlebowski RT, McTiernan A (1999) Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer. J Clin Oncol 17: 130–142

    PubMed  CAS  Google Scholar 

  • Col NF, Hirota LK, Orr RK, Erban JK, Wong JB, Laer J (2001) Hormone replacement therapy after breast cancer: A systematic review and quantitative assessment of risk. J Clin Oncol 19: 2357

    PubMed  CAS  Google Scholar 

  • Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348: 977–980

    Article  PubMed  CAS  Google Scholar 

  • Davies SR (1996) Premature ovarian failure. Maturitas 23: 1–8

    Article  Google Scholar 

  • Eicher W, Breckwoldt M, Riedel HH, Runnebaum B (1996) Kommt es durch Hysterektomie zur vorzeitigen Ovarialinsuffizienz? Frauenarzt 37: 50–54

    Google Scholar 

  • Espeland MA, Rapp SR, Shumaker SA et al. (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: women’s health initiative memory study. Obstet Gynecol Surv 59(10): 712–714

    Article  Google Scholar 

  • Felson DT, Nevitt MC (1999) Estrogen and osteoarthritis: how do we explain conflicting study results? Preventive Med 28: 445–448

    Article  CAS  Google Scholar 

  • Feskanich D, Willett W, Colditz G (2002) walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 288: 2300–2306

    Article  PubMed  Google Scholar 

  • Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsour K, Vogel V (1999) Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91: 1829–1846

    Article  PubMed  CAS  Google Scholar 

  • Grady D, Herrington D, Bittner V et al. (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 288: 49–57

    Article  PubMed  Google Scholar 

  • Granberg S, Ylöstalo P, Wikland M, Larlsson B (1997) Endometrial sonographic and histologic findings in women with and without hormonal replacement therapy suffering from postmenopausal bleeding. Maturitas 27: 35–40

    Article  PubMed  CAS  Google Scholar 

  • Greendale GA, Lee NP, Arriola ER (1999) The menopause. Lancet 353: 571–580

    Article  PubMed  CAS  Google Scholar 

  • Grodstein F, Stampfer MJ, Manson JE, Colditz JE, Willett WC, Rosner B, Speizer FE, Hennekens CH (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335: 453–461

    Article  PubMed  CAS  Google Scholar 

  • Grodstein F, Stampfer MJ, Colditz GA et al. (1997) Postmenopausal hormone therapy and mortality. New Engl J Med 336: 1769–1775

    Article  PubMed  CAS  Google Scholar 

  • Grodstein F, Manson JAE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ (2000) A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133: 933–941

    PubMed  CAS  Google Scholar 

  • Hadji P, Wüster C, Emons G, Schulz KD (1998) Prävention der Osteoporose — eine Herausforderung für die gynäkologische Praxis. Frauenarzt 39: 1864–1877

    Google Scholar 

  • Haskell SG, Richardson ED, Horwitz RI (1997) The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 50: 1249–1264

    Article  PubMed  CAS  Google Scholar 

  • Hauser GA (1997) Das larvierte klimakterische Syndrom. J Menopause 4: 7–15

    Google Scholar 

  • Hays J, Ockene JK, Brunner RL et al. (2003) Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348: 1839–1854

    Article  PubMed  CAS  Google Scholar 

  • Henderson VW (1997) Estrogen, cognition, and a woman’s risk of Alzheimer’s disease. Am J Med 103: 11S–18S

    Article  PubMed  CAS  Google Scholar 

  • Herrington DM, Reboussin DM, Brosnihan KB et al. (2000) Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 343: 522–529

    Article  PubMed  CAS  Google Scholar 

  • Hodis HN, Mack WJ, Azen SP et al. (2003) Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 349: 535–545

    Article  PubMed  CAS  Google Scholar 

  • Hodis HN, Mack WJ, Lobo RA et al. (2001) Estrogen in the prevention of atherosclerosis. Ann Intern Med 135: 939–953

    PubMed  CAS  Google Scholar 

  • Hodsman AB, Hanley DA, Ettinger MP et al. (2004) Efficacy and safety of human parathyroid hormone-(1–84) in increasing bone mineral density in postmenopausal osteoporosis. Obstet Gynecol Surv 59(5): 356–358

    Article  Google Scholar 

  • Holmberg L, Anderson H, for the HABITS Steering Data Monitoring Committees (2004) HABITS (hormonal replacement therapy after breast cancer — is it safe?): a randomized comparison trial stopped. Obstet Gynecol Surv 59(6): 442–443

    Article  Google Scholar 

  • Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Ass 280: 605–613

    Article  CAS  Google Scholar 

  • Irwin ML, Yasui Y, Ulrich CM et al. (2003) Effect of exercise on total and intraabdominal body fat in postmenopausal women: a randomized, controlled trial. JAMA 289: 323–330

    Article  PubMed  Google Scholar 

  • Jick H, Derby LE, Wald Myers M, Vasilakis C, Newton KM (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens. Lancet 348: 981–983

    Article  PubMed  CAS  Google Scholar 

  • Kessel B (2004) Hip fracture prevention in postmenopausal women. Obstet Gynecol Surv 59(6): 446–455

    Article  PubMed  Google Scholar 

  • Korhonen MO, Symons JP, Hyde BM, Rowan JP, Wilborn WH (1997) Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study) Am J Obstet Gynecol 176: 377–380

    Article  PubMed  CAS  Google Scholar 

  • Kousteni S, Chen J-R, Bellido T et al. (2002) Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298: 843–846

    Article  PubMed  CAS  Google Scholar 

  • Kuhl H (1996) Kardiovaskuläre Protektion durch Östrogen/Gestagen-Substitution. Dtsch Ärztebl 93: A1116–A1119

    Google Scholar 

  • Kuhl H (1997) Depressive Verstimmungen und Steroidhormone des Ovars. Arch Gynecol Obstet 260: 515–528

    Google Scholar 

  • Kuhl H (1999) Klimakterium, Postmenopause und Hormontherapie. Bremen: UNI-MED

    Google Scholar 

  • Kuhl H, Taubert HD (1987) Das Klimakterium: Pathophysiologie — Klinik — Therapie. Stuttgart: Thieme

    Google Scholar 

  • Kweansik Min K, Munarriz R, Yerxa BR et al. (2002) Selective P2Y2 receptor agonists stimulate vaginal moisture in ovariectomized rabbits. Fertil Steril 79: 393–398

    Google Scholar 

  • Lobo RA (2004) Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women. Arch Intern Med 164: 482–484

    Article  PubMed  Google Scholar 

  • MacLennan AH (2004) Obstet Gynecol Surv 59(2): 65–67

    Article  PubMed  Google Scholar 

  • Manson JAE, Hsia J, Johnson KC et al. (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349: 523–534

    Article  PubMed  CAS  Google Scholar 

  • McClung M (2004) Parathyroid hormone for the treatment of osteoporosis. Obstet Gynecol Surv 59(12): 826–832

    Article  PubMed  Google Scholar 

  • McKenzie J, Jaap AJ, Gallacher S et al. (2004) Metabolic, inflammatory, and hemostatic effects of a low-dose continuous combined hrt in women with type 2 diabetes: potentially safer with respect to vascular risk. Obstet Gynecol Surv 59(7): 524–525

    Article  Google Scholar 

  • Meade TW (1997) Hormone replacement therapy and haemostatic function. Thrombos Haemostas 78: 765–769

    CAS  Google Scholar 

  • Meunier PJ, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350: 459–468

    Article  PubMed  CAS  Google Scholar 

  • Meunier PJ, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. Obstet Gynecol Surv 59(7): 526–527

    Article  Google Scholar 

  • Miller P, Lukert B, Broy S, Civitelli R, Fleischmann R et al. (1998) Management of postmenopausal osteoporosis for primary care. Menopause 5: 123–131

    PubMed  CAS  Google Scholar 

  • Miller PD, Barlas S, Benneman SK et al. (2004) An approach to identifying osteopenic women at increased short-term risk of fracture. Obstet Gynecol Surv 59(11): 768

    Article  Google Scholar 

  • NAMS (2000) Consensus Opinion of The North American Menopause Society. Menopause 7: 5–13

    Google Scholar 

  • Naessen T, Lindmark B, Larsen HC (1997) Better postural balance in elderly women receiving estrogens. Am J Obstet Gynecol 177: 412–416

    Article  PubMed  CAS  Google Scholar 

  • North American Menopause Society (2000) Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: Consensus opinion. Menopause 7: 87–95

    Article  Google Scholar 

  • Notelovitz M, Varner RE, Rebar RW et al. (1997) Minimal endometrial proliferation over a two-year period in postmenopausal women taking 0,3 mg of unopposed esterified estrogens. Menopause 4: 80–88

    Google Scholar 

  • O’Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS (2001) Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst 93: 754

    Article  PubMed  CAS  Google Scholar 

  • Ortmann O, König K (2005) Hormontherapie im Klimakterium und in der Postmenopause. Dtsch Ärztebl 102: 144–147

    Google Scholar 

  • Penotti M, Fabio E, Modena AB et al. (2003) Effect of soy-derived isoflavones on hot flashes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 79: 1112–1117

    Article  PubMed  Google Scholar 

  • Pickar JH, Thorneycroft I, Whitehead M (1998) Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. Am J Obstet Gynecol 178: 1087–1099

    Article  PubMed  CAS  Google Scholar 

  • Pinkerton JV, Santen R (1999) Alternatives to the use of estrogen in postmenopausal women. Endocr Rev 20: 308–320

    Article  PubMed  CAS  Google Scholar 

  • Reid IR, Brown JP, Burckhardt P et al. (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346: 653–661

    Article  PubMed  CAS  Google Scholar 

  • Sami Jabara LK, Christenson CY, Wang JM et al. (2003a) Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab 88: 484–492

    Article  PubMed  CAS  Google Scholar 

  • Schneider DL, Barrett-Connor EL, Morton DJ (1997) Timing of postmenopausal estrogen for optimal bone mineral density. J Am Med Ass 277: 543–547

    Article  CAS  Google Scholar 

  • Schulte HM (1997) Osteoporose: Diagnose, Therapie und Prophylaxe. Gynäkologe 30: 352–356

    Article  Google Scholar 

  • Seibel MJ, Baylink DJ, Farley JR et al. (1997) Basic science and clinical utility of biochemical markers of bone turnover — a congress report. Exp Clin Endocrinol Diabetes 105: 125–133

    PubMed  CAS  Google Scholar 

  • Shumaker SA, Legault C, Rapp SR et al. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. the women’s health initiative memory study: a randomized, controlled trial. JAMA 289: 2651–2662

    Article  PubMed  CAS  Google Scholar 

  • Shumaker SA, Legault C, Kuller L et al. (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women’s health initiative memory study. JAMA 291: 2947–2958

    Article  PubMed  CAS  Google Scholar 

  • Siris ES, Chen Y-T, Abbott TA et al. (2004) Bone mineral density thresholds for pharmacologic intervention to prevent fractures. Arch Intern Med 164: 1108–1112

    Article  PubMed  Google Scholar 

  • Spencer CP, Morris EP, Rymer JM (1999) Selective estrogen receptor modulators: women’s panacea for the next millenium? Am J Obstet Gynecol 180: 763–770

    Article  PubMed  CAS  Google Scholar 

  • Stearns V, Beebe KL, Iyengar M, Dube E (2003) Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized, controlled trial. JAMA 289: 2827–2834

    Article  PubMed  CAS  Google Scholar 

  • Surrey ES (1999) Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Fertil Steril 71: 420–424

    Article  PubMed  CAS  Google Scholar 

  • Takeshi M, Mishell DR Jr, Ben-Chetrit A et al. (2002) Vaginalrings delivering progesterone and estradiol may be a new method of hormone replacement therapy. Fertil Steril 78: 1010–1016

    Article  Google Scholar 

  • The Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291: 1701–1712

    Article  Google Scholar 

  • Tice JA, Ettinger B, Ensrud K et al. (2003) Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ice) studya randomized, controlled trial. JAMA 290: 207–214

    Article  PubMed  CAS  Google Scholar 

  • Wassertheil-Smoller S, Hendrix SL, Limacher M et al. (2003) Effect of estrogen plus progestin on stroke in postmenopausal women: the women’s health initiative-a randomized trial. JAMA 289: 2673–2684

    Article  PubMed  CAS  Google Scholar 

  • Waters DD, Alderman J Hsia J et al. (2002) Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288: 2432–2440

    Article  PubMed  CAS  Google Scholar 

  • Watts NB (2001) Risedronate for the prevention and treatment of postmenopausal osteoporosis: results from recent clinical trials. Osteoporos Int Suppl 3: S17–S22

    Article  Google Scholar 

  • Women’s Health Initiative Steering Committee (ed) (2004) Effects of conjugated equine estrogen in postmenopausal women having undergone hysterectomy: the women’s health initiative randomized, controlled trials. Obstet Gynecol Surv 59(8): 599–600

    Google Scholar 

  • Writing Group for the Estradiol Clotting Factors Study (1996) Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. Thrombos Haemostas 75: 476–480

    Google Scholar 

  • Writing Group for the PEPI Trial (1996) Effects of hormone therapy on bone mineral density. J Am Med Ass 276: 1389–1396

    Article  Google Scholar 

  • Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321–333

    Article  Google Scholar 

  • World Health Organisation (1981) Report of a WHO scientific group. Research on the menopause. WHO Tech Rep Ser 670: 3–120

    Google Scholar 

  • Zandi PP, Carlson MC, Plassman BL et al. (2002) Hormone replacement therapy and incidence of alzheimer disease in older women: the cache county study. JAMA 288: 2123–2129

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Experimentelle Endokrinologie, Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt

    H. Kuhl (Prof. Dr. med.)

Authors
  1. H. Kuhl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt

    Manfred Kaufmann (Prof. Dr. med.) (Prof. Dr. med.)

  2. Universitätsfrauenklinik, Otto-von Guericke-Universität Magdeburg, Gerhart-Hauptmann-Straße 35, 39108, Magdeburg

    Serban D. Costa (Prof. Dr. med., Dr. h.-c.) (Prof. Dr. med., Dr. h.-c.)

  3. Frauenklinik, Klinikum St. Marien Amberg, Mariahilfbergweg 7, 92211, Amberg

    Anton Scharl (Prof. Dr. med.) (Prof. Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Kuhl, H. (2006). Klimakterium, Postmenopause und Senium. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31105-X_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-31105-X_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25664-9

  • Online ISBN: 978-3-540-31105-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation